Login to Your Account



Nasdaq and Other Hurdles

Reverse Merger Returns Vary Widely: Weighing the Risk

By Trista Morrison


Monday, July 25, 2011
With the market for initial public offerings (IPO) refusing to heat up as many had hoped, biotech companies are once again turning to reverse mergers for entry to the public markets.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription